المؤلفون: Smit KC; Department of Epidemiology, Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Utrecht, THE NETHERLANDS., Derksen JWG; Department of Epidemiology, Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Utrecht, THE NETHERLANDS., Stellato RK; Department of Data Science and Biostatistics, Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Utrecht, THE NETHERLANDS., VAN Lanen AS; Division of Human Nutrition and Health, Wageningen University & Research, Wageningen, THE NETHERLANDS., Wesselink E; Division of Human Nutrition and Health, Wageningen University & Research, Wageningen, THE NETHERLANDS., Belt EJT; Department of Surgery, Albert Schweitzer Hospital, Dordrecht, THE NETHERLANDS., Balen MC; Department of Medical Oncology, Groene Hart Hospital, Gouda, THE NETHERLANDS., Coene PPLO; Department of Surgery, Maasstad Hospital, Rotterdam, THE NETHERLANDS., Dekker JWT; Department of Surgery, Reinier de Graaf Hospital, Delft, THE NETHERLANDS., DE Groot JW; Department of Medical Oncology, Isala Hospital, Zwolle, THE NETHERLANDS., Haringhuizen AW; Department of Medical Oncology, Ziekenhuis Gelderse Vallei, Ede, THE NETHERLANDS., VAN Halteren HK; Department of Medical Oncology, Admiraal de Ruyter Hospital, Goes, THE NETHERLANDS., VAN Heek TT; Department of Surgery, Ziekenhuis Gelderse Vallei, Ede, THE NETHERLANDS., Helgason HH; Department of Medical Oncology, Haaglanden Medical Center, Den Haag, THE NETHERLANDS., Hendriks MP; Department of Medical Oncology, Northwest Clinics, Alkmaar, THE NETHERLANDS., DE Hingh IHJT; Department of Surgery, Catharina Hospital, Eindhoven, THE NETHERLANDS., Hoekstra R; Department of Medical Oncology, Ziekenhuisgroep Twente, Hengelo, THE NETHERLANDS., Houtsma D; Department of Medical Oncology, Haga Hospital, Den Haag, THE NETHERLANDS., Janssen JJB; Department of Medical Oncology, Canisius Wilhelmina Hospital, Nijmegen, THE NETHERLANDS., Kok N; Department of Gastrointestinal Oncology, Antoni Van Leeuwenhoek-Netherlands Cancer Institute, Amsterdam, THE NETHERLANDS., Konsten JLM; Department of Surgery, Viecuri Hospital, Venlo, THE NETHERLANDS., Los M; Department of Medical Oncology, St. Antonius Hospital, Nieuwegein, THE NETHERLANDS., Meijerink MR; Department of Radiology and Nuclear Medicine, VU Medical Center, Amsterdam, THE NETHERLANDS., Mekenkamp LJM; Department of Medical Oncology, Medisch Spectrum Twente, Enschede, THE NETHERLANDS., Peeters KCMJ; Department of Surgery, Leiden University Medical Center, University of Leiden, Leiden, THE NETHERLANDS., Polée MB; Department of Medical Oncology, Medical Center Leeuwarden, Leeuwarden, THE NETHERLANDS., Rietbroek RC; Department of Medical Oncology, Rode Kruis Hospital, Beverwijk, THE NETHERLANDS., Schiphorst AHW; Department of Surgery, Diakonessenhuis Hospital, Utrecht, THE NETHERLANDS., Schrauwen RWM; Department of Gastroenterology and Hepatology, Bernhoven Hospital, Uden, THE NETHERLANDS., Schreinemakers J; Department of Surgery, Amphia Hospital, Breda, THE NETHERLANDS., Sie MPS; Department of Medical Oncology, ZorgSaam Hospital, Terneuzen, THE NETHERLANDS., Simkens L; Department of Medical Oncology, Maxima Medical Center, Eindhoven, THE NETHERLANDS., Sonneveld EJA; Department of Surgery, Dijklander Hospital, Hoorn, THE NETHERLANDS., Terheggen F; Department of Medical Oncology, Bravis Hospital, Roosendaal, THE NETHERLANDS., Iersel LV; Maastricht University Medical Center, Department of Internal Medicine, Division of Medical Oncology, GROW, Maastricht University, Maastricht, THE NETHERLANDS., Vles WJ; Department of Surgery, Ikazia Hospital, Rotterdam, THE NETHERLANDS., Wasowicz-Kemps DK; Department of Surgery, Elisabeth-TweeSteden Hospital, Tilburg, THE NETHERLANDS., DE Wilt JHW; Department of Surgery, Radboud University Medical Center, University of Nijmegen, Nijmegen, THE NETHERLANDS., Kok DE; Division of Human Nutrition and Health, Wageningen University & Research, Wageningen, THE NETHERLANDS., Winkels RM; Division of Human Nutrition and Health, Wageningen University & Research, Wageningen, THE NETHERLANDS., Kampman E; Division of Human Nutrition and Health, Wageningen University & Research, Wageningen, THE NETHERLANDS., VAN Duijnhoven FJB; Division of Human Nutrition and Health, Wageningen University & Research, Wageningen, THE NETHERLANDS., Koopman M; Department of Medical Oncology, University Medical Center Utrecht, Utrecht University, Utrecht, THE NETHERLANDS., May AM; Department of Epidemiology, Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Utrecht, THE NETHERLANDS.

المصدر: Medicine and science in sports and exercise [Med Sci Sports Exerc] 2024 Apr 01; Vol. 56 (4), pp. 623-634. Date of Electronic Publication: 2023 Nov 27.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 8005433 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1530-0315 (Electronic) Linking ISSN: 01959131 NLM ISO Abbreviation: Med Sci Sports Exerc Subsets: MEDLINE

مواضيع طبية MeSH: Quality of Life* , Colorectal Neoplasms*/diagnosis, Male ; Humans ; Female ; Exercise ; Cohort Studies ; Fatigue

المؤلفون: van der Sijde F; Erasmus MC Cancer Institute, Department of Surgery, University Medical Center Rotterdam, Rotterdam, Netherlands., Dik WA; Laboratory of Medical Immunology, Department of Immunology, Erasmus MC, University Medical Center Rotterdam, Rotterdam, Netherlands., Mustafa DAM; Tumor Immuno-Pathology Laboratory, Department of Pathology, Erasmus MC, University Medical Center Rotterdam, Rotterdam, Netherlands., Vietsch EE; Erasmus MC Cancer Institute, Department of Surgery, University Medical Center Rotterdam, Rotterdam, Netherlands., Besselink MG; Cancer Center Amsterdam, Department of Surgery, Amsterdam UMC, University of Amsterdam, Amsterdam, Netherlands., Debets R; Laboratory of Tumor Immunology, Department of Medical Oncology, Erasmus MC, University Medical Center Rotterdam, Rotterdam, Netherlands., Koerkamp BG; Erasmus MC Cancer Institute, Department of Surgery, University Medical Center Rotterdam, Rotterdam, Netherlands., Haberkorn BCM; Department of Medical Oncology, Maasstad Hospital, Rotterdam, Netherlands., Homs MYV; Department of Medical Oncology, Erasmus MC, University Medical Center Rotterdam, Rotterdam, Netherlands., Janssen QP; Erasmus MC Cancer Institute, Department of Surgery, University Medical Center Rotterdam, Rotterdam, Netherlands., Luelmo SAC; Department of Medical Oncology, Leiden University Medical Center, Leiden, Netherlands., Mekenkamp LJM; Department of Medical Oncology, Medisch Spectrum Twente, Enschede, Netherlands., Oostvogels AAM; Laboratory of Tumor Immunology, Department of Medical Oncology, Erasmus MC, University Medical Center Rotterdam, Rotterdam, Netherlands., Smits-Te Nijenhuis MAW; Laboratory of Medical Immunology, Department of Immunology, Erasmus MC, University Medical Center Rotterdam, Rotterdam, Netherlands., Wilmink JW; Cancer Center Amsterdam, Department of Medical Oncology, Amsterdam UMC, University of Amsterdam, Amsterdam, Netherlands., van Eijck CHJ; Erasmus MC Cancer Institute, Department of Surgery, University Medical Center Rotterdam, Rotterdam, Netherlands.

مؤلفون مشاركون: Dutch Pancreatic Cancer Group

المصدر: Frontiers in immunology [Front Immunol] 2022 Aug 25; Vol. 13, pp. 898498. Date of Electronic Publication: 2022 Aug 25 (Print Publication: 2022).

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE

مواضيع طبية MeSH: Carcinoma, Pancreatic Ductal*/pathology , Pancreatic Neoplasms*/pathology, Antineoplastic Combined Chemotherapy Protocols/therapeutic use ; Chemokine CCL4 ; Cytokines/therapeutic use ; Fluorouracil ; Humans ; Interleukin 1 Receptor Antagonist Protein/therapeutic use ; Interleukin-18 ; Interleukin-7 ; Irinotecan ; Leucovorin ; Oxaliplatin ; Pancreatic Neoplasms

المؤلفون: Smit KC; Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, 3508 GA Utrecht, The Netherlands.; Department of Medical Oncology, University Medical Center Utrecht, Utrecht University, 3584 CX Utrecht, The Netherlands., Derksen JWG; Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, 3508 GA Utrecht, The Netherlands., Beets GLO; Department of Surgery, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands.; GROW School for Oncology and Developmental Biology, Maastricht University, 6200 MD Maastricht, The Netherlands., Belt EJT; Department of Surgery, Albert Schweitzer Hospital, Albert Schweitzerplaats 25, 3318 AT Dordrecht, The Netherlands., Berbée M; Department of Radiotherapy, Maastro Clinic, 6202 NA Maastricht, The Netherlands., Coene PPLO; Department of Surgery, Maasstad Hospital, Maasstadweg 21, 3079 DZ Rotterdam, The Netherlands., van Cruijsen H; Department of Medical Oncology, Antonius Hospital, 8600 BA Sneek, The Netherlands., Davidis MA; Department of Medical Oncology, Rivas, Banneweg 57, 4204 AA Gorinchem, The Netherlands., Dekker JWT; Department of Surgery, Reinier de Graaf Hospital, Reinier de Graafweg 5, 2600 GA Delft, The Netherlands., van Dodewaard-de Jong JM; Department of Medical Oncology, Meander Medical Center, Maatweg 3, 3813 TZ Amersfoort, The Netherlands., Haringhuizen AW; Department of Medical Oncology, Ziekenhuis Gelderse Vallei, 6710 HN Ede, The Netherlands., Helgason HH; Department of Medical Oncology, Haaglanden Medical Center, 2501 CK Den Haag, The Netherlands., Hendriks MP; Department of Medical Oncology, Northwest Clinics, 1800 AM Alkmaar, The Netherlands., Hoekstra R; Department of Medical Oncology, Ziekenhuisgroep Twente, Zilvermeeuw 1, 7609 PP Hengelo, The Netherlands., de Hingh IHJT; Department of Surgery, Catharina Hospital, Michelangelolaan 2, 5623 EJ Eindhoven, The Netherlands., IJzermans JNM; Department of Surgery, Erasmus MC Cancer Institute, University Medical Center Rotterdam, 3000 AD Rotterdam, The Netherlands., Janssen JJB; Department of Medical Oncology, Canisius Wilhelmina Hospital, 6500 GS Nijmegen, The Netherlands., Konsten JLM; Department of Surgery, Viecuri Hospital, Tegelseweg 210, 5912 BL Venlo, The Netherlands., Los M; Department of Medical Oncology, St. Antonius Hospital, 3430 EM Nieuwegein, The Netherlands., Mekenkamp LJM; Department of Medical Oncology, Medisch Spectrum Twente, 7500 KA Enschede, The Netherlands., Nieboer P; Department of Medical Oncology, Wilhelmina Hospital, 9400 RA Assen, The Netherlands., Peeters KCMJ; Department of Surgery, Leiden University Medical Center, University of Leiden, Postzone K6-39 Albinusdreef 2, 2300 RC Leiden, The Netherlands., Peters NAJB; Department of Medical Oncology, Sint Jans Hospital, Vogelsbleek 5, 6001 BE Weert, The Netherlands., Pruijt HJFM; Department of Medical Oncology, Jeroen Bosch Hospital, 5200 ME Den Bosch, The Netherlands., Quarles van Ufford-Mannesse P; Department of Medical Oncology, Haga Hospital, Els Borst-Eilersplein 275, 2545 AA Den Haag, The Netherlands., Rietbroek RC; Department of Medical Oncology, Rode Kruis Hospital, Vondellaan 13, 1942 LE Beverwijk, The Netherlands., Schiphorst AHW; Department of Surgery, Diakonessenhuis Hospital, Bosboomstraat 1, 3582 KE Utrecht, The Netherlands., Schouten van der Velden A; Department of Surgery, St. Jansdal Hospital, Wethouder Jansenlaan 90, 3844 DG Harderwijk, The Netherlands., Schrauwen RWM; Department of Gastroenterology and Hepatology, Bernhoven Hospital, Nistelrodeseweg 10, 5406 PT Uden, The Netherlands., Sie MPS; Department of Medical Oncology, ZorgSaam Hospital, Wielingenlaan 2, 4535 PA Terneuzen, The Netherlands., Sommeijer DW; Department of Medical Oncology, Academisch Medisch Centrum, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands.; Department of Medical Oncology, Flevo Hospital, Hospitaalweg 1, 1315 RA Almere, The Netherlands., Sonneveld DJA; Department of Surgery, Dijklander Hospital, Waterlandlaan 250, 1441 RN Purmerend, The Netherlands., Stockmann HBAC; Department of Surgery, Spaarne Hospital, 2000 AK Haarlem, The Netherlands., Tent M; Department of Medical Oncology, Treant Hospital, 7800 RA Emmen, The Netherlands., Terheggen F; Department of Medical Oncology, Bravis Hospital, Boerhaavelaan 25, 4708 AE Roosendaal, The Netherlands., Tjin-A-Ton MLR; Department of Medical Oncology, Rivierenland Hospital, 4000 HA Tiel, The Netherlands., Valkenburg-van Iersel L; Department of Medical Oncology, Maastricht University Medical Center, 6202 NA Maastricht, The Netherlands., van der Velden AMT; Department of Medical Oncology, Tergooi Hospital, Van Riebeeckweg 212, 1213 XZ Hilversum, The Netherlands., Vles WJ; Department of Surgery, Ikazia Hospital, Montessoriweg 1, 3083 AN Rotterdam, The Netherlands., van Voorthuizen T; Department of Medical Oncology, Rijnstate Hospital, Postus 9555, 6800 TA Arnhem, The Netherlands., Wegdam JA; Department of Surgery, Elkerliek Hospital, Wesselmanlaan 25, 5707 HA Helmond, The Netherlands., de Wilt JHW; Department of Surgery, Radboud University Medical Center, University of Nijmegen, 6500 HB Nijmegen, The Netherlands., Koopman M; Department of Medical Oncology, University Medical Center Utrecht, Utrecht University, 3584 CX Utrecht, The Netherlands., May AM; Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, 3508 GA Utrecht, The Netherlands., On Behalf Of The Plcrc Study Group

المصدر: Cancers [Cancers (Basel)] 2022 Feb 16; Vol. 14 (4). Date of Electronic Publication: 2022 Feb 16.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: MDPI Country of Publication: Switzerland NLM ID: 101526829 Publication Model: Electronic Cited Medium: Print ISSN: 2072-6694 (Print) Linking ISSN: 20726694 NLM ISO Abbreviation: Cancers (Basel) Subsets: PubMed not MEDLINE

المؤلفون: van der Sijde F; Department of Surgery, Erasmus MC Cancer Institute, University Medical Center Rotterdam, 3000 CA Rotterdam, The Netherlands., Homs MYV; Department of Medical Oncology, Erasmus MC, University Medical Center Rotterdam, 3000 CA Rotterdam, The Netherlands., van Bekkum ML; Department of Medical Oncology, Reinier de Graaf Gasthuis, 2625 AD Delft, The Netherlands., van den Bosch TPP; Department of Pathology, Erasmus MC, University Medical Center Rotterdam, 3000 CA Rotterdam, The Netherlands., Bosscha K; Department of Surgery, Jeroen Bosch Hospital, 5223 GZ 's Hertogenbosch, The Netherlands., Besselink MG; Department of Surgery, Cancer Center Amsterdam, Amsterdam UMC, University of Amsterdam, 1105 AZ Amsterdam, The Netherlands., Bonsing BA; Department of Surgery, Leiden University Medical Center, 2333 ZA Leiden, The Netherlands., de Groot JWB; Isala Oncology Center, Isala Hospital, 8025 AB Zwolle, The Netherlands., Karsten TM; Department of Surgery, Onze Lieve Vrouwe Gasthuis, 1061 AE Amsterdam, The Netherlands., Groot Koerkamp B; Department of Surgery, Erasmus MC Cancer Institute, University Medical Center Rotterdam, 3000 CA Rotterdam, The Netherlands., Haberkorn BCM; Department of Medical Oncology, Maasstad Hospital, 3079 DZ Rotterdam, The Netherlands., Luelmo SAC; Department of Medical Oncology, Leiden University Medical Center, 2333 ZA Leiden, The Netherlands., Mekenkamp LJM; Department of Medical Oncology, Medisch Spectrum Twente, 7512 KZ Enschede, The Netherlands., Mustafa DAM; Tumor Immuno-Pathology Laboratory, Department of Pathology, Erasmus MC, University Medical Center Rotterdam, 3000 CA Rotterdam, The Netherlands., Wilmink JW; Department of Medical Oncology, Cancer Center Amsterdam, Amsterdam UMC, University of Amsterdam, 1105 AZ Amsterdam, The Netherlands., van Eijck CHJ; Department of Surgery, Erasmus MC Cancer Institute, University Medical Center Rotterdam, 3000 CA Rotterdam, The Netherlands., Vietsch EE; Department of Surgery, Erasmus MC Cancer Institute, University Medical Center Rotterdam, 3000 CA Rotterdam, The Netherlands., On Behalf Of The Dutch Pancreatic Cancer Group

المصدر: International journal of molecular sciences [Int J Mol Sci] 2021 Oct 09; Vol. 22 (20). Date of Electronic Publication: 2021 Oct 09.

نوع المنشور: Clinical Study; Journal Article; Multicenter Study

بيانات الدورية: Publisher: MDPI Country of Publication: Switzerland NLM ID: 101092791 Publication Model: Electronic Cited Medium: Internet ISSN: 1422-0067 (Electronic) Linking ISSN: 14220067 NLM ISO Abbreviation: Int J Mol Sci Subsets: MEDLINE

مواضيع طبية MeSH: Antineoplastic Combined Chemotherapy Protocols/*administration & dosage , Biomarkers, Tumor/*genetics , MicroRNAs/*genetics , Pancreatic Neoplasms/*drug therapy, Adult ; Aged ; Aged, 80 and over ; Antigens, Tumor-Associated, Carbohydrate/blood ; Antineoplastic Combined Chemotherapy Protocols/pharmacology ; Disease Progression ; Female ; Fluorouracil/administration & dosage ; Fluorouracil/pharmacology ; Gene Expression Regulation, Neoplastic ; Humans ; Irinotecan/administration & dosage ; Irinotecan/pharmacology ; Leucovorin/administration & dosage ; Leucovorin/pharmacology ; Male ; Middle Aged ; Multivariate Analysis ; Oxaliplatin/administration & dosage ; Oxaliplatin/pharmacology ; Pancreatic Neoplasms/blood ; Pancreatic Neoplasms/genetics ; Prospective Studies

المؤلفون: van der Sijde F; Department of Surgery, Erasmus MC, University Medical Center, Rotterdam, The Netherlands., Azmani Z; Center for Biomics, Erasmus MC, University Medical Center, Rotterdam, The Netherlands., Besselink MG; Department of Surgery, Cancer Center Amsterdam, Amsterdam UMC, University of Amsterdam, Amsterdam, Noord-Holland, The Netherlands., Bonsing BA; Department of Surgery, Leiden University Medical Center, Leiden, Zuid-Holland, The Netherlands., de Groot JWB; Isala Oncology Center, Isala Hospital, Zwolle, Overijssel, The Netherlands., Groot Koerkamp B; Department of Surgery, Erasmus MC, University Medical Center, Rotterdam, The Netherlands., Haberkorn BCM; Department of Medical Oncology, Maasstad Hospital, Rotterdam, The Netherlands., Homs MYV; Department of Medical Oncology, Erasmus MC, University Medical Center, Rotterdam, The Netherlands., van IJcken WFJ; Center for Biomics, Erasmus MC, University Medical Center, Rotterdam, The Netherlands., Janssen QP; Department of Surgery, Erasmus MC, University Medical Center, Rotterdam, The Netherlands., Lolkema MP; Department of Medical Oncology, Erasmus MC, University Medical Center, Rotterdam, The Netherlands., Luelmo SAC; Department of Medical Oncology, Leiden University Medical Center, Leiden, Zuid-Holland, The Netherlands., Mekenkamp LJM; Department of Medical Oncology, Medisch Spectrum Twente, Enschede, Overijssel, The Netherlands., Mustafa DAM; Department of Pathology, Tumor Immuno-Pathology Laboratory, Erasmus MC, University Medical Center, Rotterdam, The Netherlands., van Schaik RHN; Department of Clinical Chemistry, Erasmus MC, University Medical Center, Rotterdam, Zuid-Holland, The Netherlands., Wilmink JW; Department of Medical Oncology, Cancer Center Amsterdam, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands., Vietsch EE; Department of Surgery, Erasmus MC, University Medical Center, Rotterdam, The Netherlands., van Eijck CHJ; Department of Surgery, Erasmus University Medical Center, P.O. box 2040, Rotterdam, 3000 CA, The Netherlands.

المصدر: Therapeutic advances in medical oncology [Ther Adv Med Oncol] 2021 Aug 18; Vol. 13, pp. 17588359211033704. Date of Electronic Publication: 2021 Aug 18 (Print Publication: 2021).

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Sage Country of Publication: England NLM ID: 101510808 Publication Model: eCollection Cited Medium: Print ISSN: 1758-8340 (Print) Linking ISSN: 17588340 NLM ISO Abbreviation: Ther Adv Med Oncol Subsets: PubMed not MEDLINE

المؤلفون: Rovers KP; Department of Surgery, Catharina Hospital, PO Box 1350, 5602 ZA, Eindhoven, Netherlands., Bakkers C; Department of Surgery, Catharina Hospital, PO Box 1350, 5602 ZA, Eindhoven, Netherlands., Simkens GAAM; Department of Surgery, Catharina Hospital, PO Box 1350, 5602 ZA, Eindhoven, Netherlands., Burger JWA; Department of Surgery, Catharina Hospital, PO Box 1350, 5602 ZA, Eindhoven, Netherlands., Nienhuijs SW; Department of Surgery, Catharina Hospital, PO Box 1350, 5602 ZA, Eindhoven, Netherlands., Creemers GM; Department of Medical Oncology, Catharina Hospital, PO Box 1350, 5602, Eindhoven, ZA, Netherlands., Thijs AMJ; Department of Medical Oncology, Catharina Hospital, PO Box 1350, 5602, Eindhoven, ZA, Netherlands., Brandt-Kerkhof ARM; Department of Surgical Oncology, Erasmus Medical Centre, PO Box 2040, 3000, Rotterdam, CA, Netherlands., Madsen EVE; Department of Surgical Oncology, Erasmus Medical Centre, PO Box 2040, 3000, Rotterdam, CA, Netherlands., Ayez N; Department of Surgical Oncology, Erasmus Medical Centre, PO Box 2040, 3000, Rotterdam, CA, Netherlands., de Boer NL; Department of Surgical Oncology, Erasmus Medical Centre, PO Box 2040, 3000, Rotterdam, CA, Netherlands., van Meerten E; Department of Medical Oncology, Erasmus MC Cancer Institute, PO Box 2040, 3000, Rotterdam, CA, Netherlands., Tuynman JB; Department of Surgery, Amsterdam University Medical Centres, Location VUMC, PO Box 7057, 1007, Amsterdam, MB, Netherlands., Kusters M; Department of Surgery, Amsterdam University Medical Centres, Location VUMC, PO Box 7057, 1007, Amsterdam, MB, Netherlands., Sluiter NR; Department of Surgery, Amsterdam University Medical Centres, Location VUMC, PO Box 7057, 1007, Amsterdam, MB, Netherlands., Verheul HMW; Department of Medical Oncology, Amsterdam University Medical Centres, Location VUMC, PO Box 7057, 1007, Amsterdam, MB, Netherlands., van der Vliet HJ; Department of Medical Oncology, Amsterdam University Medical Centres, Location VUMC, PO Box 7057, 1007, Amsterdam, MB, Netherlands., Wiezer MJ; Department of Surgery, St. Antonius Hospital, PO Box 2500, 3430, Nieuwegein, EM, Netherlands., Boerma D; Department of Surgery, St. Antonius Hospital, PO Box 2500, 3430, Nieuwegein, EM, Netherlands., Wassenaar ECE; Department of Surgery, St. Antonius Hospital, PO Box 2500, 3430, Nieuwegein, EM, Netherlands., Los M; Department of Medical Oncology, St. Antonius Hospital, PO Box 2500, 3430, Nieuwegein, EM, Netherlands., Hunting CB; Department of Medical Oncology, St. Antonius Hospital, PO Box 2500, 3430, Nieuwegein, EM, Netherlands., Aalbers AGJ; Department of Surgical Oncology, Netherlands Cancer Institute, PO Box 90203, 1006, Amsterdam, BE, Netherlands., Kok NFM; Department of Surgical Oncology, Netherlands Cancer Institute, PO Box 90203, 1006, Amsterdam, BE, Netherlands., Kuhlmann KFD; Department of Surgical Oncology, Netherlands Cancer Institute, PO Box 90203, 1006, Amsterdam, BE, Netherlands., Boot H; Department of Gastrointestinal Oncology, Netherlands Cancer Institute, PO Box 90203, 1006, Amsterdam, BE, Netherlands., Chalabi M; Department of Gastrointestinal Oncology, Netherlands Cancer Institute, PO Box 90203, 1006, Amsterdam, BE, Netherlands., Kruijff S; Department of Surgery, University Medical Centre Groningen, PO Box 30001, 9700 RB, Groningen, RB, Netherlands., Been LB; Department of Surgery, University Medical Centre Groningen, PO Box 30001, 9700 RB, Groningen, RB, Netherlands., van Ginkel RJ; Department of Surgery, University Medical Centre Groningen, PO Box 30001, 9700 RB, Groningen, RB, Netherlands., de Groot DJA; Department of Medical Oncology, University Medical Centre Groningen, PO Box 30001, 9700, Groningen, RB, Netherlands., Fehrmann RSN; Department of Medical Oncology, University Medical Centre Groningen, PO Box 30001, 9700, Groningen, RB, Netherlands., de Wilt JHW; Department of Surgery, Radboud University Medical Centre, PO Box 9101, 6500, Nijmegen, HB, Netherlands., Bremers AJA; Department of Surgery, Radboud University Medical Centre, PO Box 9101, 6500, Nijmegen, HB, Netherlands., de Reuver PR; Department of Surgery, Radboud University Medical Centre, PO Box 9101, 6500, Nijmegen, HB, Netherlands., Radema SA; Department of Medical Oncology, Radboud University Medical Centre, PO Box 9101, 6500, Nijmegen, HB, Netherlands., Herbschleb KH; Department of Medical Oncology, Radboud University Medical Centre, PO Box 9101, 6500, Nijmegen, HB, Netherlands., van Grevenstein WMU; Department of Surgery, University Medical Centre Utrecht, PO Box 85500, 3508, Utrecht, GA, Netherlands., Witkamp AJ; Department of Surgery, University Medical Centre Utrecht, PO Box 85500, 3508, Utrecht, GA, Netherlands., Koopman M; Department of Medical Oncology, University Medical Centre Utrecht, PO Box 85500, 3508, Utrecht, GA, Netherlands., Haj Mohammad N; Department of Medical Oncology, University Medical Centre Utrecht, PO Box 85500, 3508, Utrecht, GA, Netherlands., van Duyn EB; Department of Surgery, Medisch Spectrum Twente, PO Box 50000, 7500, Enschede, KA, Netherlands., Mastboom WJB; Department of Surgery, Medisch Spectrum Twente, PO Box 50000, 7500, Enschede, KA, Netherlands., Mekenkamp LJM; Department of Medical Oncology, Medisch Spectrum Twente, PO Box 50000, 7500, Enschede, KA, Netherlands., Nederend J; Department of Radiology, Catharina Hospital, PO Box 1350, 5602, Eindhoven, ZA, Netherlands., Lahaye MJ; Department of Radiology, Netherlands Cancer Institute, PO Box 90203, 1006, Amsterdam, BE, Netherlands., Snaebjornsson P; Department of Pathology, Netherlands Cancer Institute, PO Box 90203, 1006, Amsterdam, BE, Netherlands., Verhoef C; Department of Surgical Oncology, Erasmus Medical Centre, PO Box 2040, 3000, Rotterdam, CA, Netherlands., van Laarhoven HWM; Department of Medical Oncology, Amsterdam University Medical Centres, Location AMC, PO Box 22660, 1100, Amsterdam, DD, Netherlands., Zwinderman AH; Department of Clinical Epidemiology, Biostatistics & Bioinformatics, Amsterdam University Medical Centres, Location AMC, PO Box 22660, 1100, Amsterdam, DD, Netherlands., Bouma JM; Clinical Trial Department, Netherlands Comprehensive Cancer Organisation (IKNL), PO Box 19079, 3501, Utrecht, DB, Netherlands., Kranenburg O; UMC Utrecht Cancer Centre, University Medical Centre Utrecht, PO Box 85500, 3508, Utrecht, GA, Netherlands., van 't Erve I; Department of Pathology, Netherlands Cancer Institute, PO Box 90203, 1006, Amsterdam, BE, Netherlands., Fijneman RJA; Department of Pathology, Netherlands Cancer Institute, PO Box 90203, 1006, Amsterdam, BE, Netherlands., Dijkgraaf MGW; Department of Clinical Epidemiology, Biostatistics & Bioinformatics, Amsterdam University Medical Centres, Location AMC, PO Box 22660, 1100, Amsterdam, DD, Netherlands., Hemmer PHJ; Department of Surgery, University Medical Centre Groningen, PO Box 30001, 9700 RB, Groningen, RB, Netherlands., Punt CJA; Department of Medical Oncology, Amsterdam University Medical Centres, Location AMC, PO Box 22660, 1100, Amsterdam, DD, Netherlands., Tanis PJ; Department of Surgery, Amsterdam University Medical Centres, Location AMC, PO Box 22660, 1100, Amsterdam, DD, Netherlands., de Hingh IHJT; Department of Surgery, Catharina Hospital, PO Box 1350, 5602 ZA, Eindhoven, Netherlands. ignace.d.hingh@catharinaziekenhuis.nl.

مؤلفون مشاركون: Dutch Peritoneal Oncology Group (DPOG), Dutch Colorectal Cancer Group (DCCG)

المصدر: BMC cancer [BMC Cancer] 2019 Apr 25; Vol. 19 (1), pp. 390. Date of Electronic Publication: 2019 Apr 25.

نوع المنشور: Clinical Trial, Phase II; Clinical Trial, Phase III; Journal Article; Randomized Controlled Trial

بيانات الدورية: Publisher: BioMed Central Country of Publication: England NLM ID: 100967800 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2407 (Electronic) Linking ISSN: 14712407 NLM ISO Abbreviation: BMC Cancer

مواضيع طبية MeSH: Colorectal Neoplasms/*drug therapy , Colorectal Neoplasms/*surgery , Peritoneal Neoplasms/*drug therapy , Peritoneum/*surgery, Adult ; Bevacizumab/administration & dosage ; Chemotherapy, Adjuvant/adverse effects ; Colorectal Neoplasms/pathology ; Combined Modality Therapy ; Cytoreduction Surgical Procedures/adverse effects ; Disease-Free Survival ; Female ; Fluorouracil/administration & dosage ; Fluorouracil/adverse effects ; Humans ; Leucovorin/administration & dosage ; Leucovorin/adverse effects ; Male ; Middle Aged ; Neoplasm Metastasis ; Oxaliplatin/administration & dosage ; Oxaliplatin/adverse effects ; Perioperative Period ; Peritoneal Neoplasms/pathology ; Peritoneal Neoplasms/secondary ; Peritoneal Neoplasms/surgery ; Peritoneum/drug effects ; Peritoneum/pathology ; Progression-Free Survival ; Quality of Life